Guardant Health Inc (GH):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Guardant Health Inc (GH) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10497
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Guardant Health Inc (Guardant Health) is a non-invasive cancer diagnostics company that commercializes genomic liquid biopsy. The company develops proprietary digital sequencing technology used to detect individual genomic alterations. It offers Guardant360, a tool for early cancer detection used during cancer treatment for residual disease monitoring and recurrence monitoring. Guardant Health also develops a cloud-based information platform for liquid biopsy-based genomic testing in cancer treatments. The company provides somatic alterations across all solid tumor sites. Guardant Health is headquartered in Redwood City, California, the US.

Guardant Health Inc (GH) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Guardant Health Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Guardant Health Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Guardant Health Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Guardant Health Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Guardant Health Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Guardant Health Inc, Medical Equipment, Deal Details 11
Venture Financing 11
Guardant Health Raises USD360 Million in Venture Financing 11
Guardant Health Raises Funds in Series D Financing Round 13
Guardant Health Raises USD83 Million in Venture Financing 15
Guardant Health Raises USD50 Million in Series C Venture Financing 16
Guardant Health Raises USD56 Million in Venture Financing 17
Guardant Health Raises US$31.5 Million In Series B Venture Financing 18
Guardant Health Raises US$10 Million In Series A Financing Round 19
Partnerships 20
Guardant Health Enters into Agreement with Bristol-Myers 20
University of Texas MD Anderson Cancer Center Enters into Agreement with Guardant Health 21
Guardant Health Enters into Agreement with AstraZeneca, Merck and Pfizer 22
Guardant Health Enters into Distribution Agreement with IPS Genomix 23
Oncotest-Teva Enters into Distribution Agreement with Guardant Health 24
Guardant Health, Pangaea Biotech, Dr. Rosell Oncology Institute and Medica Scientia Innovation Research Enter into Agreement 25
Guardant Health Enters into Agreement with Principia Biopharma 26
Guardant Health Enters into Distribution Agreement with Sanomics 27
Guardant Health Enters into Agreement with Mirati Therapeutics 28
Equity Offering 29
Guardant Health Raises USD273.1 Million in IPO 29
Guardant Health Inc – Key Competitors 30
Guardant Health Inc – Key Employees 31
Guardant Health Inc – Locations And Subsidiaries 32
Head Office 32
Recent Developments 33
Legal and Regulatory 33
Jul 18, 2018: Foundation Medicine and Guardant Health Agree to Settle Patent Infringement Lawsuit 33
Product News 34
Dec 14, 2017: Liquid Biopsy Results Differed Substantially Between Two Providers 34
Other Significant Developments 35
Sep 05, 2018: Guardant Health reports cyber attack and information breach 35
Jun 03, 2017: Cure-One Announces Partnership with Guardant Health 36
May 11, 2017: Guardant Health Partners with SoftBank to Accelerate Efforts in Early Cancer Detection 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Guardant Health Inc, Medical Equipment, Key Facts, 2017 2
Guardant Health Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Guardant Health Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Guardant Health Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Guardant Health Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Guardant Health Inc, Deals By Market, 2012 to YTD 2018 8
Guardant Health Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Guardant Health Raises USD360 Million in Venture Financing 11
Guardant Health Raises Funds in Series D Financing Round 13
Guardant Health Raises USD83 Million in Venture Financing 15
Guardant Health Raises USD50 Million in Series C Venture Financing 16
Guardant Health Raises USD56 Million in Venture Financing 17
Guardant Health Raises US$31.5 Million In Series B Venture Financing 18
Guardant Health Raises US$10 Million In Series A Financing Round 19
Guardant Health Enters into Agreement with Bristol-Myers 20
University of Texas MD Anderson Cancer Center Enters into Agreement with Guardant Health 21
Guardant Health Enters into Agreement with AstraZeneca, Merck and Pfizer 22
Guardant Health Enters into Distribution Agreement with IPS Genomix 23
Oncotest-Teva Enters into Distribution Agreement with Guardant Health 24
Guardant Health, Pangaea Biotech, Dr. Rosell Oncology Institute and Medica Scientia Innovation Research Enter into Agreement 25
Guardant Health Enters into Agreement with Principia Biopharma 26
Guardant Health Enters into Distribution Agreement with Sanomics 27
Guardant Health Enters into Agreement with Mirati Therapeutics 28
Guardant Health Raises USD273.1 Million in IPO 29
Guardant Health Inc, Key Competitors 30
Guardant Health Inc, Key Employees 31

List of Figures
Guardant Health Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Guardant Health Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Guardant Health Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Guardant Health Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Guardant Health Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Guardant Health Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Guardant Health Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Guardant Health Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Guardant Health Inc (GH):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PT Dahana:企業の戦略・SWOT・財務情報
    PT Dahana - Strategy, SWOT and Corporate Finance Report Summary PT Dahana - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Galardi Group, Inc.:企業の戦略・SWOT・財務情報
    Galardi Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Galardi Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • GWA Group Limited (GWA):企業の財務・戦略的SWOT分析
    GWA Group Limited (GWA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Nexstim Plc (NXTMH)-医療機器分野:企業M&A・提携分析
    Summary Nexstim Plc (Nexstim) is a medical technology company, which focuses on navigated brain stimulation (NBS) to improve rehabilitation in stroke patients non-invasively . Its NBS system, which is FDA cleared and CE-marked, applies navigated transcranial magnetic stimulation (nTMS) device for pr …
  • Shuttle Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Shuttle Pharmaceuticals Inc (Shuttle), formerly Shuttle Pharmaceuticals LLC is a developer of therapies that offers novel drugs for improving cancer treatment outcomes. The company’s pipeline products comprise therapies such as SP-2-001, SP-1-161, SP-1-003 and SP-3-001. Its therapies are use …
  • Community Health Systems Inc (CYH)-製薬・医療分野:企業M&A・提携分析
    Summary Community Health Systems Inc. (CHS) is an operator of general acute care hospitals and outpatient facilities in communities. The company’s services include general acute care services, emergency room services, general and specialty surgery, critical care, internal medicine, obstetrics and di …
  • PACCAR Inc.:戦略・SWOT・企業財務分析
    PACCAR Inc. - Strategy, SWOT and Corporate Finance Report Summary PACCAR Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Navayuga Infotech Pvt. Ltd.:企業の戦略的SWOT分析
    Navayuga Infotech Pvt. Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • DSE, Inc.:企業の戦略・SWOT・財務情報
    DSE, Inc. - Strategy, SWOT and Corporate Finance Report Summary DSE, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • VLP Therapeutics LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary VLP Therapeutics LLC (VLP) is a biopharmaceutical company that develops therapeutic vaccines and next generation of targeted antibody agents to address global unmet medical needs. The company offers product such as vaccines for the treatment of cancer types such as breast, lung, prostate can …
  • Aptuit LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Aptuit LLC (Aptuit) is a developer and manufacturer of pharmaceutical drug. The company offers drug design and discovery, IND enabling programs, integrated chemistry, manufacture and control and indigo. It drug discovery capabilities includes medicinal chemistry, computational chemistry, pha …
  • China Daye Non-Ferrous Metals Mining Limited:企業の戦略・SWOT・財務情報
    China Daye Non-Ferrous Metals Mining Limited - Strategy, SWOT and Corporate Finance Report Summary China Daye Non-Ferrous Metals Mining Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • United Supermarkets LLC:戦略・SWOT・企業財務分析
    United Supermarkets LLC - Strategy, SWOT and Corporate Finance Report Summary United Supermarkets LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Thai Rubber Latex Corp (Thailand) Public Co Ltd (TRUBB):企業の財務・戦略的SWOT分析
    Thai Rubber Latex Corp (Thailand) Public Co Ltd (TRUBB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’ …
  • Steinhoff International Holdings NV (SNH):企業の財務・戦略的SWOT分析
    Steinhoff International Holdings NV (SNH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • AVEO Pharmaceuticals Inc (AVEO):製薬・医療:M&Aディール及び事業提携情報
    Summary AVEO Pharmaceuticals Inc (AVEO) is a biopharmaceutical company which focuses on the discovery, development and commercialization of drugs for the treatment of various types of cancers. Its proprietary platform delivers insights into cancer and related diseases. AVEO develops its lead candida …
  • Enbridge Energy Partners LP (EEP)-エネルギー分野:企業M&A・提携分析
    Summary Enbridge Energy Partners, L.P. (EEP) is an independent midstream energy company. The company owns and operates crude oil and liquid petroleum transportation and storage assets, and natural gas gathering, treating, processing, transportation and marketing assets in the US. Its portfolio of as …
  • Investor AB (INVE B):企業の財務・戦略的SWOT分析
    Investor AB (INVE B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Alder Biopharmaceuticals Inc (ALDR):製薬・医療:M&Aディール及び事業提携情報
    Summary Alder Biopharmaceuticals Inc (Alder) is a biopharmaceutical company which develops, produces and markets monoclonal antibody therapeutics for the treatment of migraine, Cushing’s disease and autoimmune and inflammatory diseases. The company uses technologies such as the antibody selection sy …
  • Companhia Energetica de Sao Paulo:企業の発電所・SWOT分析2018
    Companhia Energetica de Sao Paulo - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆